Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
41 participants
OBSERVATIONAL
2021-04-06
2023-02-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Effects of Cold Exposure on Cardiovascular System
NCT06652425
Chronic Passive Heating in Healthy Older Adults
NCT05618197
Acute Health Effects of Low Temperature Exposure
NCT06076629
Identification of Critical Thermal Environments for Aged Adults
NCT04284397
Temperature Control During Dialysis Treatment
NCT00438295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1 consists of first time donors undergoing all 8 tracked plasmaphereses.
Plasmapheresis
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor.
Group 2
Group 2 consists of first time donors undergoing only last 4 plasmaphereses, serving as control for the first 4 donations.
Plasmapheresis
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Plasmapheresis
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 50:50 man and woman
Exclusion Criteria
2. Subjects undergoing stronger anti-aging interventions
40 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Hradec Kralove
OTHER
Longevitytech.fund a.s.
UNKNOWN
Clock Foundation
UNKNOWN
AGECURVE LIMITED
UNKNOWN
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pavel Borsky
M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charles University, Medical Faculty in Hradec Kralove
Hradec Králové, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202103 P07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.